Solara Active Pharma Sciences Ltd Partly Paidup
Ticker: SOLARAPP1
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
448.10
Market Cap
Debt/Equity
ROE %
PB
Promoter %
Pledge %
1Y Rev Growth %
5Y Rev Growth %
NP Margin %
NP Margin 5Y Avg %
Trading Reference
1M Return %
8.924
6M Return %
68.459
1Y Return %
-3.082
% Away 52W High
23.845
% Away 52W Low
109.051
Daily Volume
51
Investment Verdict
Avoid
Score 0/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 40/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
80%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Solara Active Pharma Sciences Ltd Partly Paidup is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend. If the stock breaks through the resistance level, it could see significant upside. However, if it fails to hold the support, there could be a downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
N
NXT-Infra Trust
NXT-Infra Trust shows potential in the infrastructure sector but faces challenges in growth consistency and valuation metrics.
View details
S
SBI Silver ETF
The SBI Silver ETF presents a decent investment opportunity with growth potential, but investors should be cautious of market volatility and execution risks.
View details
S
Shriram Nifty 1D Rate Liquid ETF
The Shriram Nifty 1D Rate Liquid ETF shows decent fundamentals but faces challenges in growth and profitability, making it a cautious investment.
View details
A
Aditya Birla Sun Life CRISIL Broad Based Gilt ETF
The ETF is a decent investment for conservative investors seeking stability, but lacks high growth potential.
View details
E
Esquire Money Guarantees Ltd
Esquire Money Guarantees Ltd shows potential in a growing sector but faces significant risks and inconsistencies in performance metrics.
View details
M
Mirae Asset Nifty EV and New Age Automotive ETF
The ETF has potential in a growing sector, but risks and inconsistencies in profitability and governance warrant caution.
View details
S
SBI Nifty50 Equal Weight ETF
The SBI Nifty50 Equal Weight ETF presents a decent investment opportunity with a diversified portfolio, but investors should be cautious of market volatility and execution risks.
View details
I
ICICI Prudential Nifty Oil & Gas ETF
The ICICI Prudential Nifty Oil & Gas ETF presents a decent investment opportunity with growth potential, but investors should be cautious of sector volatility and external risks.
View details
G
Groww Nifty EV & New Age Automotive ETF
The Groww Nifty EV & New Age Automotive ETF presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
M
MITCON Consultancy & Engineering Services Ltd
MITCON Consultancy & Engineering Services Ltd has a decent outlook but faces challenges in growth consistency and market sentiment.
View details
A
Aditya Birla Sun Life CRISIL 10 Year Gilt ETF
The Aditya Birla Sun Life CRISIL 10 Year Gilt ETF offers stability but lacks significant growth potential. It is suitable for conservative investors seeking fixed income exposure.
View details
I
ICICI Prudential Nifty Metal ETF
The ICICI Prudential Nifty Metal ETF shows potential in a recovering sector but faces challenges in growth consistency and market volatility.
View details
M
Motilal Oswal Nifty India Defence ETF
The ETF is positioned well within a growing sector, but investors should be cautious of valuation and execution risks.
View details
M
Mirae Asset Nifty500 Multicap 50:25:25 ETF
The ETF shows decent potential with a diversified portfolio and consistent growth, but some risks in governance and execution need to be monitored.
View details
D
DSP Nifty Top 10 Equal Weight ETF
The DSP Nifty Top 10 Equal Weight ETF presents a balanced investment opportunity with strong fundamentals and growth potential, though some execution risks remain.
View details
X
xxxxxx
The stock presents several risks with inconsistent growth and negative market sentiment, suggesting caution for potential investors.
View details
Business Overview
Solara Active Pharma Sciences Ltd is a prominent player in the pharmaceutical sector, focusing on active pharmaceutical ingredients (APIs) and formulations. This partly paid-up stock is ideal for investors seeking exposure to the growing Indian pharma market. With a commitment to quality and innovation, Solara is well-positioned to meet the increasing global demand for healthcare solutions. Its robust pipeline and strategic partnerships enhance its market presence, making it a compelling choice for long-term growth.
- Leading player in the pharmaceutical industry
- Focus on active pharmaceutical ingredients (APIs)
- Strong commitment to quality and innovation
- Strategic partnerships for market expansion
- Ideal for investors targeting healthcare sector growth
Investment Thesis
Solara Active Pharma Sciences Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for robust future performance, making it a worthy addition to any investor's portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Digital services segment shows promising growth potential, tapping into evolving market needs.
- Valuation metrics indicate Solara is attractively priced compared to industry peers.
- Focus on innovation and R&D positions the company for long-term sustainability.
- Solid financial performance and strategic initiatives support future growth prospects.
Opportunity vs Risk
Opportunities
- Growing demand for active pharma ingredients
- Expanding product portfolio
- Strategic partnerships in the industry
- Potential for international market expansion
Risks ⚠️
- Regulatory challenges in pharma sector
- Volatility in raw material prices
- Dependence on a few key clients
- Market competition from established players
Peer Perspective
Solara Active Pharma Sciences Ltd trades at a discount compared to peers like Aarti Drugs and Granules India. A rerating could occur with improved margin stability and consistent revenue growth in its specialty segments.
Future Outlook
Solara Active Pharma Sciences Ltd is well-positioned for growth, driven by strong market demand and innovative products; however, successful execution and effective cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What is Solara Active Pharma Sciences Ltd?A: Solara Active Pharma Sciences Ltd is a pharmaceutical company focused on active pharmaceutical ingredients and formulations.
- Q: What does 'partly paid-up' mean?A: 'Partly paid-up' indicates that only a portion of the share's total value has been paid by the investor.
- Q: Is Solara listed on Indian stock exchanges?A: Yes, Solara Active Pharma Sciences Ltd is listed on the National Stock Exchange and Bombay Stock Exchange in India.
- Q: What are the main products of Solara?A: Solara primarily produces active pharmaceutical ingredients for various therapeutic segments including anti-infectives and pain management.
- Q: How can I invest in Solara shares?A: You can invest in Solara shares through a registered stockbroker or an online trading platform.
📊 Stock Investment Checklist (100 Points)
Solara Active Pharma Sciences Ltd Partly Paidup • Updated: 2025-09-17 16:56:15
-
10BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighRevenue growth has been inconsistent, with some fluctuations.
-
10ProfitabilityHighROE and ROCE are moderate; cash flow is stable but not exceptional.
-
8ValuationHighValuation metrics are slightly above industry average.
-
6BalanceGoodDebt levels are manageable, but liquidity could be improved.
-
5GovernanceGoodPromoter holding is decent, but some pledging exists.
-
4DriversGoodGrowth drivers are present, but execution risks are notable.
-
3TechnicalsLowMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
The stock shows potential but carries risks that warrant caution. Investors should monitor performance closely.